XML 16 R10.htm IDEA: XBRL DOCUMENT v2.4.0.8
Acquisitions
9 Months Ended
Sep. 30, 2013
Acquisitions  
Acquisitions

(4) Acquisitions and Investments in Unconsolidated Affiliates

 

As a significant part of its growth strategy, the Company primarily acquires controlling interests in centers. The Company accounts for its business combinations under the fundamental requirements of the acquisition method of accounting and under the premise that an acquirer be identified for each business combination. The acquirer is the entity that obtains control of one or more businesses in the business combination and the acquisition date is the date the acquirer achieves control. The assets acquired, liabilities assumed and any noncontrolling interests in the acquired business at the acquisition date are recognized at their fair values as of that date, and the direct costs incurred in connection with the business combination are recorded and expensed separately from the business combination. Acquisitions in which the Company is able to exert significant influence but does not have control are accounted for using the equity method. Equity method investments are initially recorded at cost, unless such investments are a result of the Company entering into a transaction whereby the Company loses control of a previously controlled entity but retains a noncontrolling interest. Such transactions, which result in the deconsolidation of a previously consolidated entity, are measured at fair value.

 

During the nine months ended September 30, 2013 and 2012, the Company, through a wholly owned subsidiary, acquired a controlling interest in four centers and three centers, respectively. One of the centers acquired during 2012 was subsequently merged into an existing center.

 

The aggregate amount paid for the centers acquired and for settlement of purchase price payable obligations during the nine months ended September 30, 2013 and 2012 was approximately $59,455,000 and $16,097,000, respectively, and was paid in cash and funded by a combination of operating cash flow and borrowings under the Company's revolving credit facility. The total fair value of an acquisition includes an amount allocated to goodwill, which results from the centers' favorable reputations in their markets, their market positions and their ability to deliver quality care with high patient satisfaction consistent with the Company's business model.

 

In conjunction with the Company's acquisition of 17 centers from National Surgical Care, Inc. (“NSC”) on September 1, 2011, the Company agreed to pay as additional consideration an amount up to $7,500,000 based on a multiple of the excess earnings over the targeted earnings of the acquired centers, if any, from the period of January 1, 2012 to December 31, 2012

The acquisition date fair value of the total consideration transferred and acquisition date fair value of each major class of consideration for the acquisitions completed in the nine months ended September 30, 2013 and 2012 are as follows (in thousands):

  Nine Months Ended September 30,
  2013 2012
       
Accounts receivable $ 3,082 $ 323
Supplies, inventory, prepaid and other current assets   1,801   143
Property and equipment   5,357   1,203
Goodwill   91,545   21,940
Other intangible assets   -   150
Accounts payable   (1,482)   (104)
Other accrued liabilities   (416)   (137)
Long-term debt   (2,561)   -
       
 Total fair value   97,326   23,518
 Less: Fair value attributable to noncontrolling interests   38,123   9,250
       
 Acquisition date fair value of total consideration transferred $ 59,203 $ 14,268

Fair value attributable to noncontrolling interests is based on significant inputs that are not observable in the market. Key inputs used to determine the fair value include financial multiples used in the purchase of noncontrolling interests in centers. Such multiples, based on earnings, are used as a benchmark for the discount to be applied for the lack of control or marketability. The fair value of noncontrolling interests for acquisitions where the purchase price allocation is not finalized may be subject to adjustment as the Company completes its initial accounting for acquired intangible assets. For the nine months ended September 30, 2013 and 2012, respectively, approximately $56,173,000 and $13,255,000 of goodwill recorded was deductible for tax purposes. In connection with the transactions discussed above, the Company incurred and expensed in other operating expenses approximately $285,000 and $128,000 in acquisition related costs, primarily attorney's fees, for the nine months ended September 30, 2013 and 2012, respectively

Revenues and net earnings included in the nine months ended September 30, 2013 and 2012 associated with these acquisitions are as follows (in thousands):

 

  Nine Months Ended September 30,
  2013 2012
       
Revenues $ 6,422 $ 1,979
       
Net earnings   1,922   623
Less: Net earnings attributable to noncontrolling interests   1,081   329
       
 Net earnings attributable to AmSurg Corp. common shareholders $ 841 $ 294

The unaudited consolidated pro forma results for the nine months ended September 30, 2013 and 2012, assuming all 2013 acquisitions had been consummated on January 1, 2012 and all 2012 acquisitions had been consummated on January 1, 2011, are as follows (in thousands, except per share data):

    Nine Months Ended September 30,
    2013 2012
         
Revenues  $ 816,926 $ 827,087
Net earnings    196,126   194,315
Amounts attributable to AmSurg Corp. common shareholders:      
 Net earnings from continuing operations    55,253   57,258
 Net earnings    54,968   56,100
 Net earnings from continuing operations per common share:      
  Basic  $ 1.77 $ 1.86
  Diluted  $ 1.73 $ 1.81
 Net earnings:       
  Basic  $ 1.76 $ 1.83
  Diluted  $ 1.72 $ 1.78
 Weighted average number of shares and share equivalents:      
  Basic    31,267   30,727
  Diluted    31,912   31,558

During the nine months ended September 30, 2013, the Company entered into a transaction whereby it contributed cash plus a controlling interest in one center in exchange for a noncontrolling interest in an entity that, after the completion of the transaction, controls the contributed center and one additional center. Management of the Company believes this structure provides both economies of scale and potential future growth opportunities in the market. As a result of the transaction, the Company recorded in the accompanying consolidated balance sheets the fair value of the noncontrolling interest in the entity which now controls the contributed centers of approximately $5,201,000 as a component of investments in unconsolidated affiliates and long term notes receivable. The Company also recognized a gain on deconsolidation in the accompanying consolidated statements of earnings and comprehensive income of approximately $2,237,000. Such gain was determined based on the difference between the fair value of the Company's noncontrolling interest in the new entity and the carrying value of both the tangible and intangible assets of the contributed center immediately prior to the transaction. The fair value of the Company's noncontrolling interest was based on various estimates of the expected future earnings under likely scenarios which were weighted by the probability of each outcome using a range of expected probability of 5% to 30%. Subsequent to the completion of this transaction the center contributed by the Company was merged into the acquired center.